Anti-PGP Antibody

Catalog No : IGX-44163
262.00€
188.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Description Glycerol-3-phosphate phosphatase hydrolyzing glycerol-3-phosphate into glycerol. Thereby, regulates the cellular levels of glycerol-3-phosphate a metabolic intermediate of glucose, lipid and energy metabolism. Was also shown to have a 2-phosphoglycolate phosphatase activity and a tyrosine-protein phosphatase activity. However, their physiological relevance is unclear (PMID:26755581). In vitro, has also a phosphatase activity toward ADP, ATP, GDP and GTP .
Other names Glycerol-3-phosphate phosphatase, G3PP, EC 3.1.3.21, Aspartate-based ubiquitous Mg,2+,-dependent phosphatase, AUM, EC 3.1.3.48, Phosphoglycolate phosphatase, PGP, PGP
Cellular localization Cytoplasm
Research area Cell Biology
Note This product is for research purpose only, not for use in diagnostics or as therapeutics.
Uniprot ID A6NDG6
Product name Anti-PGP Antibody
Catalog No IGX-44163
Supplier’s Catalog No IGX-44163
Supplier ImuGeX
Host species Rabbit
Species reactivity Human
Applications ELISA, IHC, IF
Recommended dilutions IHC: 1:20-1:200, IF: 1:50-1:200
Molecular weight N/A
Conjugate Unconjugated
Immunogen Recombinant Human Glycerol-3-phosphate phosphatase protein (140-300AA)
Specificity PGP antibody detects endogenous level of PGP protein
Storage Store at +4°C for short term (1 week), for long term aliquote and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles, with each freeze and thaw cycle an antibody can lose half of its binding activity.
Clonality Polyclonal
Isotype IgG
Clone ID N/A
Concentration 1 mg/mL
Storage buffer Phosphate-buffered saline (pH 7.4) containing 0.03% Proclin and 50% Glycerol.
Formulation Liquid
Purification This antibody is immunogen affinity purified.
Handling This product contains Proclin as preservative, please take appropriate care when handling this product.
Reactivity life 12 months when stored properly according to instructions (provided antibody remains sterile).